Table 4.
Subanalysis of the different severities in DENV-2-infected patients
| Demographic Characteristicsa | Dengue fever | Severe dengue | P value | Logistic regression | |
|---|---|---|---|---|---|
| n = 1407 | n = 105 | P value | OR (95% CI) | ||
| Age (Years) | 50 (0–91) | 72 (16–91) | < 0.001 | 0.002 | 1.049 (1.018–1.082) |
| 0–59 | 921 (65.5%) | 26 (24.8%) | < 0.001 | 0.067 | 2.225 (0.947–5.228) |
| ≥60 | 486 (34.5%) | 79 (75.2%) | |||
| Sex | |||||
| Male | 719 (51.1%) | 53 (50.5%) | 0.902 | ||
| Female | 688 (48.9%) | 52 (49.5%) | |||
| Chronic diseaseb | |||||
| Diabetes mellitus | 136 (9.9%) | 26 (40.6%) | < 0.001 | 0.004 | 2.818 (1.382–5.748) |
| Hypertension | 216 (15.7%) | 29 (45.3%) | < 0.001 | 0.735 | 1.114 (0.597–2.079) |
| Congestive heart failure | 25 (1.8%) | 4 (6.3%) | 0.014 | 0.739 | 1.228 (0.367–4.114) |
| COPD | 56 (4.1%) | 9 (14.1%) | < 0.001 | 0.505 | 1.353 (0.556–3.291) |
| Cerebrovascular disease | 59 (4.3%) | 5 (7.8%) | 0.183 | ||
| Moderate to severe CKD | 13 (0.9%) | 8 (12.5%) | < 0.001 | < 0.001 | 8.065 (2.676–24.308) |
| Charlson comorbidity index scoreb | 1 (0–10) | 4.5 (0–8) | < 0.001 | 0.956 | 0.992 (0.760–1.297) |
| Outcomec | < 0.001 | ||||
| Survived | 1395 (99.3%) | 65 (63.1%) | |||
| Death | 10 (0.7%) | 38 (36.9%) | |||
aPresented as the numbers (%) except for average age and CCI score, which are shown as the median (range). The days PSO of these patients were ≤ 6 days
bN = 1,436, Dengue fever = 1,372, Severe dengue = 64. COPD Chronic obstructive pulmonary disease, CKD Chronic kidney disease
cThere are two patients who did not die from dengue fever or severe dengue